Panipenem
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(5R,6S)-3-{[(3S)-1-ethanimidoylpyrrolidin-3-yl]sulfanyl}- 6-[(1R)-1-hydroxyethyl]-7-oxo-1-azabicyclo[3.2.0]hept-2-ene- 2-carboxylic acid | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Identifiers | |
| CAS Number |
87726-17-8 |
| ATC code | J01DH55 (WHO) (with betamipron) |
| PubChem | CID 72015 |
| ChemSpider |
16736434 |
| UNII |
W9769W09JF |
| ChEMBL |
CHEMBL339323 |
| Chemical data | |
| Formula | C15H21N3O4S |
| Molar mass | 339.40 g/mol |
| |
| |
| | |
Panipenem (INN) is a carbapenem antibiotic used in combination with betamipron. It is not approved by the FDA for use in the US.
See also
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
